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The 3A protein of coxsackievirus B3 (CVB3), a small membrane protein that forms homodimers, inhibits
endoplasmic reticulum-to-Golgi complex transport. Recently, we described the underlying mechanism by
showing that the CVB3 3A protein binds to and inhibits the function of GBF1, a guanine nucleotide exchange
factor for ADP-ribosylation factor 1 (Arf1), thereby interfering with Arf1-mediated COP-I recruitment. This
study was undertaken to gain more insight into the molecular determinants underlying the interaction between
3A and GBF1. Here we show that 3A mutants that have lost the ability to dimerize are no longer able to bind
to GBF1 and trap it on membranes. Moreover, we identify a conserved region in the N terminus of 3A that is
crucial for GBF1 binding but not for 3A dimerization. Analysis of the binding domain in GBF1 showed that the
extreme N terminus, the dimerization/cyclophilin binding domain, and the homology upstream of Sec7 domain
are required for the interaction with 3A. In contrast to that of full-length GBF1, overexpression of a GBF1
mutant lacking its extreme N terminus failed to rescue the effects of 3A. Together, these data provide insight
into the molecular requirements of the interaction between 3A and GBF1.
Enteroviruses (e.g., coxsackievirus, poliovirus, and echovi-
rus) belong to the family Picornaviridae. They are nonenvel-
oped, cytolytic viruses that contain a small positive-strand
RNA genome. The viral RNA encodes a single large polypro-
tein that is processed into the individual capsid proteins and
nonstructural proteins. The nonstructural proteins are in-
volved in viral RNA replication and account for the virus-
induced alterations in host cell metabolism and structure which
serve to create an environment suitable for efficient viral RNA
replication and/or to suppress antiviral host cell responses (24,
29, 34). Enteroviruses do not rely on an intact secretory path-
way to release their virus progeny. Instead, they have been
shown to induce a general blockage of protein secretion. Inhi-
bition of protein secretion is also observed upon individual
expression of the nonstructural proteins 2B and 3A (12, 30).
The 3A-mediated inhibition of protein transport is not essen-
tial for virus replication but most likely serves to suppress
antiviral host cell responses, such as cytokine secretion and
antigen presentation (7, 11, 32).
Coxsackievirus B3 (CVB3) 3A is a small (89 amino acids
[aa]) integral membrane protein that is anchored in the mem-
brane through its C-terminal hydrophobic domain (32). Eluci-
dation of the structure of the soluble, cytosolic region up-
stream of the membrane anchor of the poliovirus 3A protein
by nuclear magnetic resonance suggested that 3A forms ho-
modimers (27). Each monomer was proposed to consist of two
amphipathic -helices, which are bent 180° to form a helical
hairpin flanked by unstructured N and C termini. The struc-
tural data suggested that dimerization was mediated by hydro-
phobic surfaces, formed mainly by hydrophobic residues in the
first amphipathic -helix (Fig. 1). Based on this structure, we
generated a molecular model of CVB3 3A and used this model
for an extensive structure-function relationship study of CVB3
3A (31). Through this approach, experimental evidence of the
functional relevance of CVB3 3A dimerization and important
insight into the structural requirements for dimerization were
obtained. The results supported the importance of a hydro-
phobic interaction between the monomers for dimerization. In
addition, regions that are important for 3A functioning but not
for dimerization were identified (31).
Recently, we elucidated the mechanism by which the CVB3
3A protein inhibits protein transport (32). We showed that
expression of 3A resulted in the disassembly of the vesicular
tubular cluster and the Golgi complex. As a result, components
of the vesicular tubular cluster and the Golgi complex flow
back to the endoplasmic reticulum (ER) and accumulate at or
close to the COP-II-coated ER exit sites, where 3A is also
localized. 3A inhibits ER-to-Golgi complex transport by block-
ing activation of the ADP-ribosylation factor 1 (Arf1) protein.
Arf proteins play a central role in protein transport and or-
ganelle structure and maintenance (15). Like other small
GTPases, Arf proteins cycle between inactive GDP-bound and
active GTP-bound states. Nucleotide exchange on Arfs is cat-
alyzed by guanine nucleotide exchange factors (GEFs) (14).
GBF1 is a GEF that has been implicated in ER-to-Golgi com-
plex transport (4, 35). Under physiological conditions, GBF1
continuously cycles on and off membranes (23, 28). We showed
that the CVB3 3A protein inhibits activation of Arf1 through
interacting with and inhibiting the function of GBF1 (32). As a
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result, the COP-I coat complex, which plays an important role
in bidirectional transport between the ER and the Golgi com-
plex (26), cannot be recruited to membranes, and protein
transport is inhibited. The poliovirus 3A protein was recently
also shown to modify Arf1 membrane association (1).
This study was undertaken to gain more insight into the
molecular determinants of the CVB3 3A-GBF1 interaction. To
this end, we tested the ability of a number of 3A mutants to
interfere with COP-I recruitment. Furthermore, the effects of
3A mutations on GBF1 binding and dynamics were investi-
gated. Finally, we identified regions in the N terminus of GBF1
that are important for the interaction with 3A.
MATERIALS AND METHODS
Cells and viruses. Buffalo green monkey (BGM) kidney cells were grown in
minimal essential medium (Gibco) supplemented with 10% fetal bovine serum.
COS-1 cells were grown in Dulbecco’s modified Eagle’s medium (Gibco) sup-
plemented with 10% fetal bovine serum. Cells were grown at 37°C in a 5% CO2
incubator. BGM cell monolayers were grown to subconfluence on coverslips in
24-well plates for immunofluorescence assays or in glass-bottomed dishes
(WillCo Wells BV) for fluorescence recovery after photobleaching (FRAP)
experiments and then transfected with 0.5 g or 1 g of plasmid DNA, respec-
tively. Transfections were performed using FuGENE 6 (Roche) according to the
manufacturer’s instructions.
Plasmids. (i) p3A-myc constructs. The plasmids coding for the mutant 3A-
Myc proteins were generated by PCR amplification, using pGFP-3A mutants as
templates. The forward and reverse primers for all mutants except the 3A-ins16S
mutant introduced SalI and BamHI sites, respectively. The forward and reverse
primers for the 3A-ins16S mutant introduced EcoRI and BamHI sites, respec-
tively. The PCR products were cloned into p3A-myc (30), from which the 3A
coding sequence was removed using the restriction enzymes SalI and BamHI.
Sequence analysis showed that all PCR products contained correct sequences.
(ii) pCFP-3A constructs. pCFP fusion constructs were generated by replacing
the green fluorescent protein (GFP) coding sequence with the cyan fluorescent
protein (CFP) coding sequence, using the restriction enzymes NheI and SspBI.
(iii) pGBT9-3A constructs. pGBT9-3A was described before (32). The other
constructs were generated by PCR amplifying the 3A coding sequences of the
mutants and cloning the PCR products into pGBT9, using the restriction en-
zymes EcoRI and BamHI.
(iv) Mammalian two-hybrid constructs. pACT-3A was described before (30).
pACT-3A mutant plasmids were obtained by replacing the wild-type (wt) 3A
sequence with mutant 3A sequences by using the enzymes Bst1107I and BamHI.
Deletion mutants of GBF1 were first generated as yellow fluorescent protein
(YFP) fusion proteins by PCR amplification. The PCR products were cloned into
pEYFP-C1 (Clontech), using the restriction enzymes BglII and SalI. Subse-
quently, the GBF1 coding sequences were removed using the restriction enzymes
BclI and SalI and cloned into pBIND that was cut with BamHI and KpnI.
(v) Venus-GBF1 constructs. Venus is a variant of YFP (22) and is referred to
as YFP in the text. YFP-GBF1 was described previously (23). YFP-GBF1N was
constructed by deleting nucleotides 1 to 111 from the GBF1 coding region.
Immunofluorescence. Immunofluorescence assays were performed as de-
scribed before (9). The effects of 3A mutant proteins on COP-I were studied by
staining 3A-Myc-expressing cells with a monoclonal anti-Myc antiserum (diluted
1:20; Sigma) and a polyclonal anti-COP-I (against - and -COP) antiserum
(diluted 1:200) (from K. Frey and F. Wieland, Biochemie-Zentrum, Heidelberg,
Germany). Pictures were taken under a Leica TCS NT microscope (Leica La-
sertechnik GmbH, Heidelberg, Germany). Alexa Fluor 594-conjugated goat anti-
rabbit immunoglobulin G and Alexa Fluor 488-conjugated anti-mouse immuno-
globulin G were obtained from Molecular Probes.
FRAP experiments. FRAP experiments were performed on a Zeiss LSM510Meta
confocal microscope (Carl Zeiss GmbH, Jena, Germany) as described previously
(32). Briefly, FRAP measurements were performed on time-lapse series that
were taken at 37°C at a rate of 1 frame per s, using a 63, 1.4-numerical-aperture
objective and pinhole settings such that-2 m optical slices were imaged. Cells
were selected on the basis of coexpression of CFP-3A and YFP-GBF1 or Arf1-
YFP. Regions of interest were selectively photobleached, using the 514-nm line
at 100% transmission.
Yeast two-hybrid analysis. Yeast two-hybrid analysis was performed with
strain AH109 (Clontech) as described previously (32). Briefly, the pGADT7 and
pGBT9 fusion constructs were transformed into yeast by the lithium acetate
method using carrier DNA and plated on nonselective plates (lacking leucine
and tryptophan). After growth, the colonies were transferred to selective plates
(lacking histidine or adenine).
Mammalian two-hybrid analysis. COS cells grown in 24-well plates were
transfected with a total of 0.75 g plasmid DNA (1:1:1 mix of the pACT, pBIND,
and pG5luc plasmids). At 48 h posttransfection, the cells were lysed, and both the
firefly luciferase and Renilla luciferase enzyme activities were measured from the
same cell lysate by use of a dual-luciferase reporter assay system (Promega) as
described previously (8). An analysis of the Renilla luciferase activities, encoded
by the pBIND plasmid and allowing monitoring of the transfection efficiency,
revealed no gross differences in efficiencies of transfection among the different
samples. All pACT- and pBIND-encoded fusion proteins were efficiently ex-
pressed (data not shown). The 3A-GBF1 interaction was expressed as the firefly
luciferase activity in cells coexpressing 3A and GBF1 fusion proteins and was
normalized to 100% for cells coexpressing wt 3A and the complete N terminus
of GBF1. The firefly luciferase activity measured in cells coexpressing mutant 3A
and GBF1 proteins was normalized to the activity measured in cells coexpressing
wt 3A and GBF1 fusion proteins (which was set at 100% in each experiment).
Coimmunoprecipitation. Coimmunoprecipitation experiments were performed as
described previously (32). Briefly, GFP or YFP fusion proteins that were coex-
pressed with 3A-Myc in BGM cells were immunoprecipitated using an anti-GFP
antibody (raised against recombinant glutathione S-transferase–GFP). The pres-
ence of 3A-Myc in these samples was checked by Western analysis using a
polyclonal anti-Myc antiserum (Affinity BioReagents).
Statistical analysis. In all graphs, data are expressed as means  standard
errors of the means. Overall statistical analysis was determined by analysis of
variance followed by Scheffe’s test to investigate significance between individual
values and control values, using Origin Pro 7.5 software (Originlabs, Northamp-
ton, MA). P values below 0.05 were considered significant.
RESULTS AND DISCUSSION
Inhibition of COP-I recruitment by mutant 3A proteins.
Previously, we constructed several 3A mutants and character-
ized them for the ability to dimerize and inhibit secretion of a
reporter protein (30, 31, 32). A number of 3A mutants were
obtained that were no longer able to inhibit reporter protein
secretion. We reasoned that this might be due to an impaired
ability to interfere with COP-I recruitment to membranes. To
investigate this, C-terminal Myc fusions of a number of se-
lected 3A mutants were generated. These mutants are summa-
rized in Fig. 2A and described below (in order of the positions
of the mutations, from the N to the C terminus). The addition
of a C-terminal Myc tag did not interfere with the abilities of
3A to dimerize (data not shown) and to inhibit protein trans-
port (13, 32).
FIG. 1. Molecular model of homodimer formed by N-terminal 60
aa of CVB3 3A. The construction of this molecular model is described
in reference 31. N, N terminus; C, C terminus. Hydrophobic residues
in the first -helix that are implicated in dimerization are indicated.
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(i) 3A-R6A/E7A/I8A/K9A/I10A is a mutant in which Arg6,
Glu7, Ile8, Lys9, and Ile10 are replaced with Ala residues. These
residues are located in the N terminus of 3A, a region that was
predicted to be unstructured and not to be involved in dimer-
ization. Indeed, we found that mutant 3A-R6A/E7A/I8A/K9A/
I10A showed efficient dimerization. Nevertheless, this mutant
was unable to inhibit reporter protein secretion. (ii) 3A-ins16S
is a mutant in which a Ser residue is inserted at position 16 in
3A. (iii) 3A-P17A/P18A/P19A is a mutant in which Pro17,
Pro18, and Pro19 are replaced with Ala residues. The last two
mutants contain amino acid alterations in the region immedi-
ately upstream of the first -helix (aa 20 to 27). Although this
region was not predicted to be important for dimerization,
both mutants were defective in 3A dimerization and inhibition
of reporter protein secretion, which may be due to overall
effects on protein folding. (iv) 3A-L25A/L26A is a mutant in
which Leu25 and Leu26 are replaced with Ala residues. These
residues are located in the first -helix and predicted to be
involved in the hydrophobic packing between the 3A mono-
mers. Consistent with this, mutant 3A-L25A/L26A was unable
to dimerize and inhibit secretion of a reporter protein. For
reasons of simplicity, mutants 3A-R6A/E7A/I8A/K9A/I10A,
3A-P17A/P18A/P19A, and 3A-L25A/L26A are referred to in
this study as 3A-REIKI, 3A-PPP, and 3A-LL, respectively.
We also generated C-terminal Myc fusions of two new 3A
mutants. These mutants contain substitutions of residues in the
middle part of 3A that are conserved among the different
enteroviruses. The mutants are (v) 3A-VDSE, a mutant in
which Val29, Asp30, Ser31, and Glu32 are replaced with Ala
residues, and (vi) 3A-VREY, a mutant in which Val34, Arg35,
Glu36, and Tyr37 are replaced with Ala residues. Both mutants
were able to inhibit reporter protein secretion and formed
dimers efficiently in mammalian two-hybrid assays (data not
shown).
Immunofluorescence microscopy of cells, using anti-COP-I
antibodies, showed that COP-I was typically localized at Golgi
FIG. 2. Inhibition of COP-I recruitment to membranes by mutant 3A proteins. (A) Amino acid sequence of CVB3 3A. The C-terminal
hydrophobic domain (aa 61 to 82) is depicted in the boxed area. Amino acids that are mutated are indicated by asterisks, and the Ser insertion
at position 16 is also indicated. (B to H) BGM cells expressing Myc-tagged wt 3A (B), 3A-REIKI (C), 3A-ins16S (D), 3A-PPP (E), 3A-LL (F),
3A-VDSE (G), and 3A-VREY (H) were stained for the Myc tag and COP-I. (I) Table summarizing the ability of 3A mutants to inhibit protein
transport and COP-I recruitment. References in which the mutants are described are indicated. 3A-REIKI, 3A-R6A/E7A/I8A/K9A/I10A; 3A-PPP,
3A-P17A/P18A/P19A; 3A-LL, 3A-L25A/L26A; 3A-VDSE, 3A-V29A/D30A/S31A/E32A; 3A-VREY, 3A-V34A/R35A/E36A/Y37A. Bars, 10 m.
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membranes in control cells. In line with previous results,
COP-I was redistributed to the cytoplasm in cells expressing
the wt 3A protein (Fig. 2B) (32). In these cells, 3A localized at
the ER and at or close to punctate structures (Fig. 2B), which
we have demonstrated previously to represent rearranged
membranes containing markers for COP-II, ER-Golgi inter-
mediate compartment, and the Golgi complex (32). In cells
expressing 3A-REIKI, 3A-ins16S, 3A-PPP, and 3A-LL (i.e.,
the 3A mutants that were unable to inhibit protein transport),
COP-I was localized at Golgi membranes (Fig. 2C to F and I).
The 3A-ins16S, 3A-PPP, and 3A-LL mutants were found to
localize at the Golgi complex (Fig. 2D, E, and F), whereas the
3A-REIKI mutant localized mainly to the ER and partially to
the Golgi complex (Fig. 2C). In contrast, the 3A-VDSE and
3A-VREY mutants (i.e., the 3A mutants that were able to
inhibit protein transport) localized similarly to wt 3A and re-
distributed COP-I to the cytoplasm (Fig. 2G, H, and I). To-
gether, the data demonstrate that defective 3A mutants cannot
inhibit protein transport since they can no longer interfere with
COP-I recruitment.
Interestingly, long thread-like tubulovesicular structures
could be observed in cells expressing wt 3A (Fig. 3) or mutant
3A proteins that were still able to inhibit transport. These
structures contained 3A, an integral membrane protein, at
their surfaces and were therefore most likely membrane tu-
bules. No such structures were observed in cells expressing any
of the defective 3A mutants.
Ability of mutant 3A proteins to bind GBF1 and trap it on
membranes. GBF1 is an Arf1 GEF that normally cycles rapidly
on and off Golgi membranes (23, 28). GBF1-mediated activa-
tion of Arf1 is required for COP-I recruitment to membranes.
We showed that wt 3A interferes with COP-I recruitment by
binding to (the N-terminal part of) GBF1 and trapping it on
membranes (32). The observation that the 3A mutants de-
scribed above are defective in interfering with COP-I recruit-
ment may be explained by their inability to bind GBF1. Alter-
natively, these mutants may still bind GBF1 but no longer be
able to trap it on membranes. To discriminate between these
possibilities, binding of these mutants to GBF1, as well as their
effects on GBF1 dynamics, was tested.
Binding of the 3A mutants to the N-terminal part of GBF1
was investigated by both yeast two-hybrid (Fig. 4A) and mam-
malian two-hybrid (Fig. 4B) analyses. In Saccharomyces cerevi-
siae, the cytosolic part of 3A (i.e., the 60 aa upstream of its
hydrophobic membrane anchor) was expressed, whereas full-
length 3A was expressed in the mammalian system. All 3A
FIG. 3. Membrane tubules in 3A-expressing BGM cells. (A and C)
BGM cells expressing Myc-tagged wt 3A, stained for the Myc tag. (B
and D) Higher-magnification pictures of the parts of the cells indicated
by the white boxes in panels A (B) and C (D), showing the tubules in
more detail. Bars, 10 m (A and C) and 2 m (B and D).
FIG. 4. Interaction of 3A mutants with GBF1 and effects on GBF1
dynamics. (A) Interaction of wt 3A, 3A-REIKI, 3A-ins16S, 3A-PPP,
3A-LL, and 3A-VREY with the N-terminal part of GBF1 in yeast
two-hybrid analysis. The upper, middle, and lower panels show growth
of yeast on nonselective medium (leucine- and tryptophan-deficient
medium [NS]), selective medium lacking histidine (	His), and selec-
tive medium lacking adenine (	Ade), respectively. (B) Interaction of
wt 3A, 3A-REIKI, 3A-ins16S, 3A-PPP, 3A-LL, and 3A-VREY with
the N-terminal part of GBF1 in mammalian two-hybrid analysis. The
firefly luciferase activities measured at 48 h posttransfection are de-
picted. The activity measured with wt 3A and the GBF1 N terminus
was set at 100%. (C) Dynamics of YFP-GBF1. FRAP traces were done
for cells expressing YFP-GBF1 together with CFP fusion proteins of
wt 3A, 3A-ins16S, 3A-PPP, 3A-LL, and 3A-VDSE. The traces show
the average recoveries (n  10 cells) for at least two independent
experiments. The fluorescence intensity before bleaching was normal-
ized to 1, and the fluorescence intensity directly after bleaching was
normalized to 0. The fluorescence intensity was corrected for bleaching
of the cell during imaging and for background fluorescence.
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mutants that were unable to inhibit protein transport and to
inhibit COP-I recruitment to membranes (3A-REIKI, 3A-
ins16S, 3A-PPP, and 3A-LL) were severely reduced in the
ability to bind GBF1 (Fig. 4A and B). In contrast, the two
mutants that were able to inhibit protein transport and to
cause release of COP-I into the cytoplasm (3A-VDSE and
3A-VREY) showed a strong interaction with GBF1 (Fig. 4A
and B). These data clearly indicate that the 3A-REIKI, 3A-
ins16S, 3A-PPP, and 3A-LL mutants are unable to inhibit
COP-I recruitment and protein transport because they cannot
bind GBF1.
Putative effects of the 3A mutant proteins on the dynamics
of GBF1 were tested using FRAP. FRAP measurements were
performed on dispersed membrane structures that contained
YFP-GBF1 and CFP-3A (32). We compared GBF1 dynamics
in cells expressing wt 3A, 3A-ins16S, 3A-PPP, 3A-LL, and
3A-VDSE. GBF1 dynamics in cells expressing 3A-REIKI and
3A-VREY was not analyzed since in these cells, for reasons
that are yet unknown, YFP-GBF1 localized at the ER rather
than on dispersed membranes (which would not allow a proper
comparison). The results showed that the 3A mutants that
were unable to inhibit protein transport (3A-ins16S, 3A-PPP,
and 3A-LL) were unable to trap GBF1 on membranes,
whereas 3A-VDSE trapped GBF1 on membranes as efficiently
as wt 3A (Fig. 4C). In summary, these findings indicate that 3A
mutants that are unable to inhibit COP-I recruitment to mem-
branes and to block protein transport are also unable to trap
GBF1 on membranes.
Previously, we showed that expression of 3A resulted in an
increased cycling time of Arf1-YFP (32). Although the under-
lying reason for this phenomenon is unclear, it seems likely
that it is linked to the 3A-mediated inhibition of GBF1. To
gain more insight into this possible correlation, we tested the
effects of the 3A mutants on Arf1 dynamics (Fig. 5). In cells
expressing 3A mutants that were able to inhibit GBF1 activity
(3A-VDSE and 3A-VREY), the half-time of fluorescence re-
covery of Arf1-YFP was decreased to an extent similar to that
for cells expressing wt 3A, whereas in cells expressing 3A
mutants that were not able to inhibit protein transport (3A-
REIKI, 3A-ins16S, 3A-PPP, and 3A-LL), the half-time of flu-
FIG. 5. Effects of 3A mutants on Arf1 dynamics. The upper panel
shows FRAP traces for cells expressing Arf1-YFP either alone (no 3A)
or together with CFP fusion proteins of wt 3A, 3A-REIKI, and 3A-
VDSE. The FRAP traces for Arf1-YFP in cells expressing 3A-ins16S,
3A-PPP, and 3A-LL were similar to that observed for cells expressing
3A-REIKI (and are therefore not shown). The FRAP trace for Arf1-
YFP in cells expressing 3A-VREY was similar to that for cells expressing
3A-VDSE. The lower panel shows half-times of fluorescence recovery
of Arf1-YFP expressed alone or together with wt 3A, 3A-REIKI,
3A-ins16S, 3A-PPP, 3A-LL, 3A-VDSE, or 3A-VREY. The traces show
the average recoveries (n  10 cells) for at least two independent
experiments. The fluorescence intensity was calculated as described in
the legend to Fig. 4.
FIG. 6. Characterization of the interaction between GBF1 and 3A. (A) Schematic representation of deletion mutants of the N terminus of
GBF1. (B) Interaction of 3A with GBF1 deletion mutants in a mammalian two-hybrid system. The firefly luciferase activities measured at 48 h
posttransfection are depicted. Average values and standard errors of the means for three experiments are shown. In each experiment, the activity
measured with 3A and the intact GBF1 N terminus was set at 100%. (C) Coimmunoprecipitation experiments. 3A-Myc was specifically
coprecipitated (IP) from cells cotransfected with YFP-GBF1 but not from cells cotransfected with YFP-GBF1N or Golgi complex-GFP. GBF1-I,
aa 1 to 710 of GBF1; GBF1-II, aa 1 to 52 and 295 to 710 of GBF1; GBF 1-III, aa 1 to 392 of GBF1; GBF1-IV, aa 1 to 566 of GBF1; GBF1-V,
aa 52 to 710 of GBF1; GBF1N, GBF1 lacking aa 1 to 37. WB, Western blot.
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orescence recovery of Arf1-YFP was slightly reduced, though
not significantly, compared to that for control cells (Fig. 5).
These results provide support for a correlation between the
activity of GBF1 and the dynamics of Arf1.
Identification of regions in the N terminus of GBF1 that are
important for interaction with 3A. We also sought to identify
the binding domain of 3A in GBF1. All ArfGEFs identified to
date have a Sec7 domain, a conserved module of 
200 aa that
carries the guanine nucleotide exchange activity and that has
been studied extensively (3, 16). In contrast to the Sec7 do-
main, only a little is known about the functions of the other
GEF domains, which are likely to determine intracellular lo-
calization and intermolecular interactions (3, 6, 10, 18, 20).
The N-terminal part of GBF1 has been shown to be sufficient
for 3A binding (32). To gain more insight into the region(s) of
GBF1 that is responsible for the interaction with 3A, we made
deletion constructs of the N terminus of GBF1 (Fig. 6A) and
tested them for interaction with 3A by mammalian two-hybrid
analysis (Fig. 6B). Two homology domains have been identi-
fied in the N-terminal part of GBF1, namely, the dimerization/
cyclophilin binding (DCB) domain and the homology up-
stream of Sec7 (HUS) domain (21). Deletion of the DCB
domain (GBF1-II) completely abrogated the interaction with
3A. Combined deletion of the HUS domain and the C-termi-
nal region downstream of this domain (GBF1-III) also abol-
ished the interaction with 3A, whereas deletion of the C-ter-
minal region alone (GBF1-IV) had no effect. Deleting the
extreme N terminus, i.e., the region upstream of the DCB
domain (GBF1-V), also abrogated the interaction with 3A.
The importance of the latter region for the interaction with 3A
was confirmed by showing that a GBF1 mutant in which the
extreme N terminus was deleted from (full-length) GBF1
(GBF1N) was no longer able to interact with 3A in coimmu-
noprecipitation experiments (Fig. 6C). Together, these data
indicate that both the extreme N terminus of GBF1 and the
DCB and HUS domains are important for the 3A-GBF1 in-
teraction. It remains to be established whether each of these
regions contains contact sites for the interaction with 3A or,
alternatively, if different parts of the protein fold together into
a higher-order structure that provides a binding site for 3A.
Elucidation of the structure of GBF1 would help to further
define the binding domain of 3A in GBF1.
A GBF1 mutant that lacks the extreme N terminus cannot
rescue the effects of 3A. Previously, we showed that overex-
pression of GBF1 suppressed 3A function (32). Whereas
COP-I is redistributed to the cytoplasm in almost all 3A-ex-
pressing cells, COP-I was still associated with membranes in
most of the cells coexpressing GBF1 and 3A. In these cells,
either an intact Golgi complex or dispersed membrane struc-
tures which contained 3A, GBF1, and several Golgi complex
markers were observed (32). We sought to investigate whether
the extreme N terminus of GBF1, which is important for the
3A-GBF1 interaction, is essential for this effect. Overexpres-
sion of GBF1 or GBF1N had little, if any, effect on the
localization of COP-I (Fig. 7A). Consistent with previous re-
sults, coexpression of GBF1 and 3A gave rise to dispersed
membrane structures that contained both proteins and that
also contained COP-I (Fig. 7B and C) (32). In contrast, COP-I
was redistributed to the cytosol in cells coexpressing GBF1N
and 3A, indicating that the N terminus of GBF1 is required for
its ability to counteract the effects of 3A (Fig. 7C). In these
cells, 3A localization was similar to that in cells expressing 3A
alone, and no colocalization with GBF1N was observed (Fig.
7B). Thus, the extreme N terminus of GBF1 is required, not
only for the interaction with 3A but also for the rescue of the
3A-mediated inhibition of Arf1 activation. Despite this corre-
lation, it remains to be established whether an interaction
between 3A and GBF1 is important for the rescue effect.
FIG. 7. A GBF1 mutant that lacks the extreme N terminus cannot
rescue the effects of 3A. (A) Cells expressing YFP-GBF1 or YFP-
GBF1N were stained for COP-I. (B) Images showing GBF1 (left)
and 3A (middle). Cells expressing YFP-GBF1 and 3A-Myc or YFP-
GBF1N and 3A-Myc were stained for the Myc tag. (C) Images
showing GBF1 (left) and COP-I (middle). Cells expressing YFP-GBF1
and 3A-Myc or YFP-GBF1N and 3A-Myc were stained for COP-I.
GBF1N, GBF1 lacking aa 1 to 37. Bars, 10 m.
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Concluding remarks. This study was undertaken to gain
more insight into the molecular determinants that are required
for the interaction between 3A and GBF1. We characterized a
number of 3A mutants and found that mutants that were
unable to inhibit protein transport were no longer able to
inhibit COP-I recruitment because they were unable to bind to
GBF1 and trap it on membranes. Previously, we showed that
dimerization is important for efficient inhibition of protein
transport (31). Here we showed that mutants that are impaired
in dimerization, i.e., mutants 3A-ins16S, 3A-PPP, and 3A-LL
(31, 32), are unable to bind GBF1, providing an explanation
for their inability to inhibit transport. The 3A-REIKI mutant
was also unable to inhibit protein transport. However, this
mutant showed efficient dimerization (31), and therefore we
speculated that the REIKI region might be involved in binding
of a cellular partner. Here we provided experimental evidence
for this hypothesis by showing that the 3A-REIKI mutant is no
longer able to bind GBF1. We hypothesize that dimerization is
required for efficient exposure of the REIKI residues. In ad-
dition, dimerization may create other contact sites in 3A (i.e.,
other than the REIKI region) for the interaction with GBsF1.
The wt 3A protein localizes at the ER and a dispersed
post-ER compartment, but most 3A mutants that were defec-
tive in inhibiting protein transport localized at the Golgi com-
plex. It can be speculated that upon its generation, 3A is first
transported to the Golgi complex, where the majority of en-
dogenous GBF1 is localized (5, 17, 35). Inhibition of GBF1 by
3A will lead to inactivation of Arf1, resulting in dissociation of
COP-I from Golgi membranes. This will lead to disassembly of
the Golgi complex since COP-I is required for maintenance
of the structural integrity of the Golgi complex (19). Treatment of
cells with brefeldin A has been shown to result in rapid Golgi
complex disassembly and in redistribution of the Golgi pro-
teins into the ER via membrane tubules that are formed in a
highly dynamic manner and that mediate retrograde transport
to the ER (19, 25). Membrane tubules were also observed in
3A-expressing cells. Thus, as in brefeldin A-treated cells, Golgi
complex disassembly and backflow into the ER in 3A-express-
ing cells probably occur via membrane tubulation. 3A mutants
that cannot inhibit GBF1 function and COP-I recruitment will
remain localized at the Golgi complex.
Recently, we showed that not only the 3A protein of CVB3
but also that of the closely related poliovirus (PV) inhibits
ER-to-Golgi complex transport by binding and inhibiting
GBF1 (33). While this work was in progress, Belov et al.
reported that Arf1 is recruited to membranes in PV-infected
cells and that Arf1-GTP levels increase approximately fourfold
during infection (2). The reason for the difference between
their data (i.e., recruitment and increased activation of Arf1
during infection in infected cells) and our data (i.e., inactiva-
tion of Arf1 and redistribution to the cytosol during expression
of 3A alone) is still unknown. A possible explanation is that
more (viral) factors modify the activation state of Arf1 during
infection. Indeed, Belov et al. showed that in addition to the
PV 3A protein, which was found to interact with GBF1, the PV
3CD protein also interacts with ArfGEFs (i.e., BIG1 and
BIG2). Thus, the regulation of Arf1 in infected cells seems to
be modulated by multiple viral proteins in a complex, and still
poorly understood, way.
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